About Synoste
Synoste is a company based in Espoo (Finland) founded in 2012 was acquired by Globus Medical in October 2020. Synoste has raised $10.98 million across 6 funding rounds from investors including Globus Medical, Finnvera and Business Finland. Synoste offers products and services including ExcelsiusGPS, Biologics, and Excelsius3D. Synoste operates in a competitive market with competitors including Biomet, Treace Medical Concepts, Bioretec, IlluminOss Medical and Loci Orthopaedics, among others.
- Headquarter Espoo, Finland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.98 M (USD)
in 6 rounds
-
Latest Funding Round
$5.89 M (USD), Series A
Oct 18, 2018
-
Investors
Globus Medical
& 10 more
-
Employee Count
Not available
-
Acquired by
Globus Medical
(Oct 21, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synoste
Synoste offers a comprehensive portfolio of products and services, including ExcelsiusGPS, Biologics, and Excelsius3D.
System for precise guidance in spine surgery procedures
Products for bone healing and tissue support in surgeries
3D imaging tool for surgical planning and execution
Funding Insights of Synoste
Synoste has successfully raised a total of $10.98M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $5.89 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synoste
Synoste has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Globus Medical, Finnvera and Business Finland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Hongjiali is engaged in providing electric vehicle charging solutions.
|
Locked | Locked | Locked | |
|
Venture capital investment in early-stage technology, life science, and Health startups
|
Locked | Locked | Locked | |
|
Early-stage venture capital is invested in European startups across sectors.
|
Locked | Locked | Locked |
Investor details for Synoste
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synoste
Investment portfolio details for Synoste
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synoste
Detailed financials for Synoste
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synoste Comparisons
Peer comparison for Synoste
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synoste
Synoste operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomet, Treace Medical Concepts, Bioretec, IlluminOss Medical and Loci Orthopaedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orthopedic surgical and non-surgical products are designed and distributed.
|
|
| Locked | Locked | Locked |
Orthopedic foot and ankle correction systems are developed and offered.
|
|
| Locked | Locked | Locked |
Provider of bioabsorbable, bioactive and drug-releasing surgical implants
|
|
| Locked | Locked | Locked |
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
|
|
| Locked | Locked | Locked |
Thumb implant for thumb base arthritis
|
|
| Locked | Locked | Locked |
Orthopedic medical devices for upper and lower extremities are developed.
|
Detailed competitors of Synoste
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synoste
Complete news archive for Synoste
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synoste
Synoste was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Synoste is headquartered in Espoo, Finland.
Synoste is a funded company, having raised a total of $10.98M across 6 funding rounds to date.
Synoste was founded in 2012 as a spin-out from Aalto University in Espoo, Finland. A medical device is being developed for treating skeletal deformities through gradual limb lengthening. Smart materials are utilized, with energy transferred via electromagnetic induction into an intramedullary nail. The bone is stretched by 27 cm over several months in the medical technology sector.
Synoste's top competitors include Treace Medical Concepts, Loci Orthopaedics and Bioretec.
Synoste offers ExcelsiusGPS, Biologics, and Excelsius3D.
Synoste has 11 investors. Key investors include Globus Medical, Finnvera, Business Finland, Hongjiali, and Innovestor.